(Q40429928)

20 September 2017

3 references

19 July 2021

22 August 2022

Complement-specific antibodies: designing novel anti-inflammatories (English)

1 reference

https://api.crossref.org/works/10.1038/NM0895-839

20 September 2017

Complement-specific antibodies: Designing novel anti-inflammatories (English)

1 reference

25 May 2024

1 reference

anti-inflammatory agent

1 reference

19 July 2021

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585191

25 May 2024

protein engineering

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585191

25 May 2024

author name string

L. A. Matis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585191

25 May 2024

S. A. Rollins

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585191

25 May 2024

language of work or name

English

0 references

publication date

1 August 1995

3 references

full work available at URL

20 September 2017

19 July 2021

22 August 2022

https://www.nature.com/articles/nm0895-839.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585191

https://europepmc.org/articles/PMC7095943

25 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585191

https://europepmc.org/articles/PMC7095943?pdf=render

25 May 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585191

http://www.nature.com/articles/nm0895-839

25 May 2024

1 reference

https://api.crossref.org/works/10.1038/NM0895-839

http://www.nature.com/articles/nm0895-839.pdf

25 May 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/NM0895-839

25 May 2024

3 references

20 September 2017

19 July 2021

22 August 2022

1

1 reference

20 September 2017

issue

8

1 reference

20 September 2017

page(s)

839-842

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0895-839

20 September 2017

exact match

0 references

cites work

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM0895-839

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

21 January 2018

1 reference

12 December 2020

Antibody-targeted drugs for the therapy of cancer

1 reference

12 December 2020

Clinical complementology: recent progress and future trends

1 reference

12 December 2020

Human antibodies from combinatorial libraries.

1 reference

12 December 2020

Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer

1 reference

12 December 2020

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

1 reference

12 December 2020

beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.

1 reference

12 December 2020

Direct selection for a catalytic mechanism from combinatorial antibody libraries

1 reference

12 December 2020

Antigen-specific human antibodies from mice comprising four distinct genetic modifications

1 reference

12 December 2020

Membrane signaling by complement C5b-9, the membrane attack complex

1 reference

12 December 2020

Molecular organization and function of the complement system

1 reference

12 December 2020

Immunosuppressive therapy as a determinant of transplantation outcomes.

1 reference

12 December 2020

Making antibodies by phage display technology

1 reference

12 December 2020

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

12 December 2020

In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5.

1 reference

12 December 2020

Building Antibodies from their Genes

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM0895-839

1 reference

release_xl72r7ijhfd4dhlz5hcdlqjkqa

20 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xl72r7ijhfd4dhlz5hcdlqjkqa

24 November 2022

mapped directly with Wikidata item

PMC publication ID

7095943

0 references

1 reference